Emerging roles of 14-3-3γ in the brain disorder

被引:20
作者
Cho, Eunsil [1 ]
Park, Jae-Yong [1 ]
机构
[1] Korea Univ, Coll Hlth Sci, Sch Biosyst & Biomed Sci, Seoul 02708, South Korea
基金
新加坡国家研究基金会;
关键词
14-3-3; gamma; protein; Brain disorders; Glioma; Inflammatory disease; Neurodegenerative disease; Neurodevelopmental disease; YWHAG; CREUTZFELDT-JAKOB-DISEASE; NEURONAL MIGRATION DELAY; CEREBROSPINAL-FLUID; STRUCTURAL BASIS; CELL-CYCLE; IN-VIVO; ALZHEIMERS-DISEASE; SUBCELLULAR-LOCALIZATION; 14-3-3GAMMA PROTEIN; MOLECULAR-CLONING;
D O I
10.5483/BMBRep.2020.53.10.158
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
14-3-3 proteins are mostly expressed in the brain and are closely involved in numerous brain functions and various brain disorders. Among the isotypes of the 14-3-3 proteins, 14-3-3 gamma is mainly expressed in neurons and is highly produced during brain development, which could indicate that it has a significance in neural development. Furthermore, the distinctive levels of temporally and locally regulated 14-3-3 gamma expression in various brain disorders suggest that it could play a substantial role in brain plasticity of the diseased states. In this review, we introduce the various brain disorders reported to be involved with 14-3-3 gamma, and summarize the changes of 14-3-3 gamma expression in each brain disease. We also discuss the potential of 14-3-3 gamma for treatment and the importance of research on specific 14-3-3 isotypes for an effective therapeutic approach.
引用
收藏
页码:500 / 511
页数:12
相关论文
共 134 条
  • [1] The role of the 14-3-3 protein family in health, disease, and drug development
    Aghazadeh, Yasaman
    Papadopoulos, Vassilios
    [J]. DRUG DISCOVERY TODAY, 2016, 21 (02) : 278 - 287
  • [2] 14-3-3-ALPHA AND 14-3-3-DELTA ARE THE PHOSPHORYLATED FORMS OF RAF-ACTIVATING 14-3-3-BETA AND 14-3-3-ZETA - IN-VIVO STOICHIOMETRIC PHOSPHORYLATION IN BRAIN AT A SER-PRO-GLU-LYS MOTIF
    AITKEN, A
    HOWELL, S
    JONES, D
    MADRAZO, J
    PATEL, Y
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (11) : 5706 - 5709
  • [3] Specificity of 14-3-3 isoform dimer interactions and phosphorylation
    Aitken, A
    Baxter, H
    Dubois, T
    Clokie, S
    Mackie, S
    Mitchell, K
    Peden, A
    Zemlickova, E
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2002, 30 : 351 - 360
  • [4] Post-translational modification of 14-3-3 isoforms and regulation of cellular function
    Aitken, Alastair
    [J]. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2011, 22 (07) : 673 - 680
  • [5] Specification of 14-3-3 proteins in Lewy bodies
    Berg, D
    Riess, O
    Bornemann, A
    [J]. ANNALS OF NEUROLOGY, 2003, 54 (01) : 135 - 135
  • [6] PURIFICATION, PROPERTIES, AND IMMUNOHISTOCHEMICAL LOCALIZATION OF HUMAN-BRAIN 14-3-3 PROTEIN
    BOSTON, PF
    JACKSON, P
    KYNOCH, PAM
    THOMPSON, RJ
    [J]. JOURNAL OF NEUROCHEMISTRY, 1982, 38 (05) : 1466 - 1474
  • [7] Bridges Dave, 2004, Sci STKE, V2004, pre10, DOI 10.1126/stke.2422004re10
  • [8] Down Syndrome
    Bull, Marilyn J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (24) : 2344 - 2352
  • [9] CSF detection of the 14-3-3 protein in unselected patients with dementia
    Burkhard, PR
    Sanchez, JC
    Landis, T
    Hochstrasser, DF
    [J]. NEUROLOGY, 2001, 56 (11) : 1528 - 1533
  • [10] Identification of 14-3-3 protein isoforms in human astrocytoma by immunohistochemistry
    Cao, Lei
    Cao, Weidong
    Zhang, Wei
    Lin, Hong
    Yang, Xiaoliang
    Zhen, Haining
    Cheng, Jinxiang
    Dong, Wenpeng
    Huo, Junli
    Zhang, Xiang
    [J]. NEUROSCIENCE LETTERS, 2008, 432 (02) : 94 - 99